rulebooks will be rewritten very soon 🔪 🫁 IASLC jto

This is a crucial issue that requires attention. Waiting an entire year for a response should not be acceptable, but unfortunately, it happens too often. In Latin America, only 14% of cancer research papers are published the same year they are completed. It is necessary to

Honored to receive the ASCO Conquer Cancer, the ASCO Foundation IDEA Award! Grateful to Ashish Singh for his constant encouragement, and to Josh Thomas Georgy & @ajoyoJohn for their invaluable guidance and insights. Excited to be part of #ASCO25 with brilliant minds worldwide!

Humbled to receive the 2025 ASCO Global Oncology Young Investigator Award! Deep gratitude to ASCO and Conquer Cancer, the ASCO Foundation for this incredible honor. Grateful to my mentors Ashish Singh, Dr Nithya Ramnath, balaji Veeraraghavan, and to CMC Vellore (Official) for unwavering support. #ASCO25 #breastcancer

What we need is a RCT looking at different local treatment modalities(hypoRT, CTRT, Sx) post induction CHEMOTHERAPY in this cohort.. ascopubs.org/doi/full/10.12…

Just responded to a medical emergency on #AirIndia flight AI504! Crew's quick response was commendable. Noted that medical kit didn't include pulse oximeter, glucose meter or portable ECG. Perhaps time to consider adding these life-saving tools to the kit? MoCA_GoI Air India

There’s an #AirAboutIndia. And it’s taking over the world. Celebrate the resounding spirit of a new India - bold, joyous, and confidently on the rise. #AirIndia #FlyAI

Congratulations 🎊 well deserved recognition of the work you have done over the last few years in this underrecognised but extremely important domain of cancer care..MASCC #ASCO25

🚨New meta-analysis of IC + CCRT in LA Cervical Cancer Results Summary 📈 2-yr OS: 85% if IC ≤6wks vs 72% if >6wks 📈 2-yr OS: 84% with platinum+taxane vs 72% with gem–platinum 🔗 doi.org/10.1016/j.ctrv… #Gyncsm #GynOnc OncoAlert 🧵For, Against, and Neutral perspectives 👇1/

**PRAGRAD: A New Approach to Treating Very Advanced Oral Cancer** latest from our group CMC Vellore MASCC @oncoalert The ASCO Post ESMO - Eur. Oncology Lizzy Smyth sciencedirect.com/science/articl…

🧬 The Liquid Biopsy Truth: What $40 Billion in Cancer Screening Really Buys Us A masterful The New Yorker investigation by Siddhartha Mukherjee reveals why finding cancer early isn't what we think it is. Here's what longevity clinics don't tell you... 🧵

🧪 Unresectable Oral Cavity Cancer: Radical Rx Feasible? This observational study shows that patient choice-driven radical treatment (URAD) in unresectable OCC led to: ✅ Better QoL (pain score ↑ from 26 ➡️ 80) ✅ Improved survival (RRAD OS: 37.9 mo vs UPA: 6.0 mo) 📊 77%

PRAGRAD, a new patient-driven treatment approach for very advanced oral cavity #cancers (which cannot be surgically removed) shows significant improvement in patient outcomes: prospective study by CMC #research team. Instead of a one-size-fits-all plan, #patients are given the

🎙️ Proud to present our work from Med Onc CMC Vellore (Official) at #MASCC25 Interim results of “MIND & MONEY” 💭💰 Mentors: Ashish Singh JENIFER JEBA SUNDARARAJ Dr Dheeraj K, MD, DM, 🇮🇳 Can we ⬇️ distress & #FinancialToxicity in pts with Stage IV cancer through structured screening + targeted referrals? 🧵👇

Congrats Praveen Kumar Marimuthu for presenting your Mind & Money study from our medonc dept CMC Vellore (Official) as oral at #MASCC25! these are major barriers to cancer care and this study is crucial progress toward equitable care. Anjana Joel Ajoy Oommen John Harikrishna kovilapu Sanuj Thomas

Congratulations Praveen Kumar Marimuthu for your eye opening work! Financial distress is a known problem for Indian cancer patients, but it is rarely measured or accounted for in practice or studies. Integrated targeted referrals improving multi- domain distress is encouraging!

💸 Why Financial Toxicity (#FinTox) matters in cancer care Key insights from Dr Fumiko Ladd Chino, MD, FASCO’s excellent plenary at #MASCC25 : 🔻 It erodes quality of life and social functioning 📉 Leads to borrowing, reduced spending on basics and leisure; the burden worsens over time 💥

authors.elsevier.com/a/1lPta1Hx52Nr… Our experience in very advanced LAHNSCC .. there is probably a role of intensified local treatment in exceptional responders..we need prospective randomised trials Tata Memorial Hospital NationalCancerGrid Vanita Noronha, MBBS MD DM sarbani ghosh-laskar Praveen Kumar Marimuthu Josh Thomas Georgy CancerCare

amazing, TMCi should be a standard treatment in every suitable patient..not only in LMIC ..

Phaeochromocytomas and Paragangliomas are rare neuroendocrine tumors arising from the chromaffin cells..But malignant versions are even rarer..Glad to be part of one of the largest Indian series on this in recent times..Published today. pubmed.ncbi.nlm.nih.gov/40735853/ Endocrine Society of India